Guardant Health saw the highest growth of 1.1% in patent filings in May and 3.49% in grants in April in Q2 2024. Compared to Q1 2024, Q2 2024 saw an increase in patent filings by 0.99% and grants by 3.49%. GlobalData’s DataBook provides a comprehensive analysis of Guardant Health‘s patent filings and grants. Buy the databook here.
Guardant Health has been focused on protecting inventions in United States(US) with 21 publications in Q2 2024
The United States(US) Patent Office dominates the patent filings and grants with nearly 55% filings and 36% grants. The United States(US), European Patent Office(EPO), World Intellectual Property Organization(WIPO), and Australia(AU) patent Office are among the top ten patent offices where Guardant Health is filings its patents. Among the top granted patent authorities, Guardant Health has 36% of its grants in United States(US), 29% in European Patent Office(EPO) and 29% in Spain(ES).
In terms of grant share, Guardant Health stands in tenth position among its competitors. and secured the top positions according to recent patent publication data.
Patents related to genomics and healthtech lead Guardant Health's portfolio
Guardant Health has the highest number of patents in genomics followed by, healthtech and rare diseases. For genomics, nearly 23% of patents were filed and 50% of patents were granted in Q2 2024.
Healthcare it related patents lead Guardant Health portfolio followed by lung cancer, and breast cancer
Guardant Health has highest number of patents in healthcare it followed by lung cancer, breast cancer, colorectal tumor, and non-small cell lung cancer. For healthcare it, nearly 9% of patents were filed and 16% of patents were granted in Q2 2024.
For comprehensive analysis of Guardant Health's filings and grants, buy the databook here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.